Atlas Trials

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Clinical trial NCT07435129 · RECRUITING

Trial details

NCT number
NCT07435129
Sponsor
Scholar Rock, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Facioscapulohumeral Muscular DystrophyFSHD
Start date
2026-07-30
Primary completion
2028-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.